About Us

Home>About Us

WHO WE ARE

ABOUT STEMIGEN THERAPEUTICS

StemiGen Therapeutics is a Singapore biotechnology company with the current focus on harnessing the regenerative properties of human mesenchymal stem cells (MSCs) and its derivatives for osteoarthritis and anti-aging applications.

OUR MISSION
  • To provide an affordable source of premium high quality MSCs that are broadly applicable to the treatment of aging related diseases to improve and enhance the quality of life for people of all ages worldwide.
  • Disseminate honest and true scientific knowledge
  • We are one of the 59 approved tissues banks in Singapore.
  • We produce high quality Mesenchymal stem cells (MSCs), NK cells and MSC derived exosomes.
  • Collaboration with local hospitals and medical institutions.
  • Global partnerships and connections.
  • Market access to patients through group-owned private clinics.
  • Subjected to strict local regulations. The Health Sciences Authority (HSA) of Singapore is designated as a World Health Organization-Listed Authority (WLA) for its medical regulatory system.

OUR TEAM

Meet Our Experts

Dr Tay Boon Keng

Dr Tay Boon Keng

Professor, Clinical Collaborator and Advisor

Singapore General Hospital: Emeritus Consultant

Dr Darren Tay Keng Jin

Dr Darren Tay Keng Jin

Assoc Prof and Clinical Collaborator

Singapore General Hospital: Senior Consultant

Mr Kelvin Lim

Mr Kelvin Lim

Chief Executive Officer

Chief Executive Officer

Dr Kenon Chua

Dr Kenon Chua

Clinical Collaborator

Singapore General Hospital: Senior Consultant

Specialist Team

Chief Operating Officer/ Chief Scientific Officer

Dr Phua was a First Class Honors Chemical Engineering graduate from the National University of Singapore (NUS). He then obtained Master’s degree qualification from University of Illnois (UIUC, USA) sponsored by Merck (previously Schering-Plough) and EDB and gained a few years of pharmaceutical process and project engineering experience.
Dr Phua obtained his Ph.D degree in Biomedical Engineering from Duke University (USA) under the mentorship of Professor Kam W. Leong, an elected member of the National Academy of Engineering (USA). Dr Phua then joined NUS as an Assistant Professor of Chemical & Biomolecular Engineering, where he set-up his own laboratory focused on mRNA therapeutics and won highly competitive grants such as Young Individual Research Grant from National Medical Research Council.
Dr Phua has many years of experience in the field of cell and gene therapy and a track record of establishing successful research collaborations with local and overseas partners such as Duke-NUS (Singapore), TRON (Germany), National Taiwan, Centre de Biophysique Moléculaire (France) and local microneedle manufacturer Micropoint.

Kyle K.L. Phua, Ph.D

Quality Manager

Ms Jannah Yusof is an inspiring team player who motivates, encourages, and challenges the limits to achieve the target. She graduated from The National University of Malaysia (UKM) with a Bachelor of Science with Honours, majoring in Microbiology. Post graduation, she gained more than five years of working experience in cell and gene therapy industry and trained lab personnel working in a cGMP environment. She also successfully assist CGTP GMP accreditation from National Pharmaceutical Regulatory Agency (NPRA).

She has vast experience in laboratory operation management and clinical research and a proven ability to communicate effectively with all levels within the organization and with external customers. 

With her professionals, Ms Jannah is responsible for developing and establishing a Quality Management System, Quality Certification and implementing StemiGen policies & procedures.

Jannah Yusof 

Production Manager

Ms Afiqah graduated from the University of Queensland (UQ) with a Bachelor of Biotechnology.

She has more than five years of working experience in GMP certified stem cells-based company. In her previous position, she managed and coordinated the overall activities of the production department. She is also responsible for continuously streamlining the production process and workflow to escalate the efficiency of production activities.

She also successfully acquired CGTP GMP accreditation by representing the production department during the National Pharmaceutical Regulatory Agency (NPRA) audit.

Nur Afiqah Mohamad

Production Officer

Edgar earned his Diploma in Mechanical Engineering (Pharmaceutical Manufacturing) from Singapore Polytechnic (SP) and has a strong passion for the biopharma industry.

With 15 years of extensive experience in the biologics and Cell & Gene Therapy (CGT) sectors, he has held various technical roles at esteemed organizations such as Innocellular Tech, Cellvec, Prime Biologics, GlaxoSmithKline (GSK), and Novartis.

Edgar Lai

WHAT WE OFFER

OUR PRODUCTS & SERVICES

Stem Cell Therapy

Stem Cell Therapy

Immune Cell Therapy

Immune Cell Therapy

Exosome Therapy

Exosome Therapy

FILL THE FORM

Make An Appointment Today